Published in J Clin Oncol on January 01, 1998
Reconsidering the family history in primary care. J Gen Intern Med (2004) 3.50
Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. Am J Hum Genet (2000) 1.07
How do women decide? Accepting or declining BRCA1/2 testing in a nationwide clinical sample in the United States. Community Genet (2006) 1.06
Management of medullary thyroid carcinoma and MEN2 syndromes in childhood. Nat Rev Endocrinol (2011) 1.05
An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. J Med Genet (2000) 1.02
Tailoring communication in consultations with women from high risk breast cancer families. Br J Cancer (2002) 0.99
To test or not to test? Moderators of the relationship between risk perceptions and interest in predictive genetic testing. J Behav Med (2005) 0.94
Determinants of preferences for genetic counselling in Jewish women. Fam Cancer (2006) 0.91
Patient responses to genetic information: studies of patients with hereditary cancer syndromes identify issues for use of genetic testing in nephrology practice. Semin Nephrol (2010) 0.83
Predictive value of breast cancer cognitions and attitudes toward genetic testing on women's interest in genetic testing for breast cancer risk. Psychosoc Med (2004) 0.78
Finding all BRCA pathogenic mutation carriers: best practice models. Eur J Hum Genet (2016) 0.75
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst (1998) 22.10
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell (1993) 13.54
Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet (2001) 7.31
Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst (1999) 6.60
Activation of macrophages in vivo and in vitro. Correlation between hydrogen peroxide release and killing of Trypanosoma cruzi. J Exp Med (1979) 5.22
A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol (2007) 5.12
Unfolding of titin immunoglobulin domains by steered molecular dynamics simulation. Biophys J (1998) 5.01
Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA (1997) 4.79
Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches. J Clin Epidemiol (2005) 4.29
Proteins as molecular chaperones. Nature (1987) 4.26
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist (2000) 3.62
Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology (1997) 3.61
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet (2000) 3.50
The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes. Clin Exp Rheumatol (2005) 3.47
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol (1997) 3.27
Correction of sickle cell disease in transgenic mouse models by gene therapy. Science (2001) 3.25
A case for including spirituality in quality of life measurement in oncology. Psychooncology (1999) 3.22
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med (1996) 3.07
Factors associated with repeat adherence to breast cancer screening. Prev Med (1990) 3.01
Patient pathways for macular disease: what will the new optometrist with special interest achieve? Eye (Lond) (2006) 2.93
Ambulatory visits to hospital emergency departments. Patterns and reasons for use. 24 Hours in the ED Study Group. JAMA (1996) 2.89
Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst (1997) 2.80
BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet (1996) 2.75
Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol (1998) 2.74
AIDS and self-organization among intravenous drug users. Int J Addict (1987) 2.73
Laboratory diagnostic techniques for Entamoeba species. Clin Microbiol Rev (2007) 2.65
Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med (1992) 2.64
Genetic risk and behavioural change. BMJ (2001) 2.64
A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer (1997) 2.53
Somatization symptoms in pediatric abdominal pain patients: relation to chronicity of abdominal pain and parent somatization. J Abnorm Child Psychol (1991) 2.50
Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion. Clin Pharmacol Ther (2008) 2.49
Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill (2010) 2.49
DNA cloning of Plasmodium falciparum circumsporozoite gene: amino acid sequence of repetitive epitope. Science (1984) 2.47
Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst (1995) 2.45
Medical evacuation from Mostar. Lancet (1996) 2.37
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet (1999) 2.36
Forced unfolding of the fibronectin type III module reveals a tensile molecular recognition switch. Proc Natl Acad Sci U S A (1999) 2.36
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. J Natl Cancer Inst (1998) 2.33
Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history. J Natl Cancer Inst (1998) 2.32
A randomized controlled trial of implant-retained mandibular overdentures. J Dent Res (2006) 2.31
Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res (1999) 2.24
Psychosocial correlates of recurrent childhood pain: a comparison of pediatric patients with recurrent abdominal pain, organic illness, and psychiatric disorders. J Abnorm Psychol (1993) 2.21
Detection of influenza A(H3N2) virus in children with suspected mumps during winter 2014/15 in England. Euro Surveill (2015) 2.19
The pharmacogenetics of chemical carcinogenesis. Pharmacogenetics (1992) 2.12
Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill (2006) 2.08
Age-related differences in the quality of life of breast carcinoma patients after treatment. Cancer (1999) 2.06
Reliability and validity of the functional assessment of cancer therapy-ovarian. J Clin Oncol (2001) 2.05
PCV-2 genotype definition and nomenclature. Vet Rec (2008) 2.04
The Todd commission's assumptions and proposals. Proc R Soc Med (1975) 2.03
Molecular characterization of the maize Rp1-D rust resistance haplotype and its mutants. Plant Cell (1999) 2.01
Ethnic differences in risk perception among women at increased risk for breast cancer. Breast Cancer Res Treat (1996) 1.94
Psychosocial antecedents of variation in girls' pubertal timing: maternal depression, stepfather presence, and marital and family stress. Child Dev (2000) 1.90
Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesi. Nature (1983) 1.90
Identification and chemical synthesis of a tandemly repeated immunogenic region of Plasmodium knowlesi circumsporozoite protein. Nature (1983) 1.90
Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Mol Psychiatry (2006) 1.89
NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology (Williston Park) (2000) 1.88
Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet (2001) 1.87
Consent to the use of stored DNA for genetics research: a survey of attitudes in the Jewish population. Am J Med Genet (2001) 1.87
Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm (2003) 1.86
Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat (1999) 1.84
A test of the cognitive diathesis-stress model of depression in children: academic stressors, attributional style, perceived competence, and control. J Pers Soc Psychol (1995) 1.84
Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveill (2011) 1.84
Instability of the L6 gene for rust resistance in flax is correlated with the presence of a linked Ac element. Plant J (1993) 1.83
Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. Int J Gynecol Cancer (2003) 1.83
Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility. Am J Med Genet (1997) 1.82
Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood (1991) 1.79
Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code. EMBO J (2000) 1.78
Why do some women get regular mammograms? Am J Prev Med (1991) 1.78
Developing and evaluating cross-cultural instruments from minimum requirements to optimal models. Qual Life Res (1993) 1.78
Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveill (2011) 1.76
Pandemic (H1N1) 2009 virus outbreak in a school in London, April-May 2009: an observational study. Epidemiol Infect (2009) 1.76
Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns (1997) 1.75
Is Swedish snus associated with smoking initiation or smoking cessation? Tob Control (2005) 1.72
Experimental infection of colostrum deprived piglets with porcine circovirus 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) potentiates PCV2 replication. Arch Virol (2000) 1.71
Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument. Qual Life Res (1997) 1.69
Effect of eating on colonic motility and transit in patients with functional diarrhea. Simultaneous scintigraphic and manometric evaluations. Gastroenterology (1991) 1.68
Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. Addict Behav (1998) 1.68
Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma. J Clin Oncol (2000) 1.67
Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst Monogr (1999) 1.66
Lateral phase separation in interfacial films of pulmonary surfactant. Biophys J (1996) 1.63
The relation of daily stressors to somatic and emotional symptoms in children with and without recurrent abdominal pain. J Consult Clin Psychol (2001) 1.62
Participation in a women's breast cancer risk counseling trial. Who participates? Who declines? High Risk Breast Cancer Consortium. Cancer (1996) 1.62
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet (1998) 1.61
Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill (2011) 1.61
Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users. AIDS (1987) 1.60
Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group. J Clin Oncol (2001) 1.58
Display rules for anger, sadness, and pain: it depends on who is watching. Child Dev (1996) 1.57
Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer (2004) 1.56
Long-term health outcomes in patients with recurrent abdominal pain. J Pediatr Psychol (1995) 1.55
The lysP gene encodes the lysine-specific permease. J Bacteriol (1992) 1.55
Anticipating clinical integration of pharmacogenetic treatment strategies for addiction: are primary care physicians ready? Clin Pharmacol Ther (2008) 1.55
Screening for germ line TP53 mutations in breast cancer patients. Cancer Res (1992) 1.55
Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study. Int J Gynecol Cancer (2007) 1.53
PCR detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in stool samples from Sydney, Australia. J Clin Microbiol (2007) 1.53
Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Inst Monogr (1994) 1.52
Multiple roles of arginine/serine-rich splicing factors in RNA processing. Biochem Soc Trans (2005) 1.52
RTOG's first quality of life study--RTOG 90-20: a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys (1995) 1.52